Johnson & Johnson’s Next Split & “1929” Hits Shelves 10/14/25
About this episode
Johnson & Johnson reported its latest earnings and announced a separation of its orthopedics business into a standalone company. CEO Joaquin Duato discusses the company’s next era, new warning labels for its multiple myeloma treatment Carvykti, and the future of J&J’s consumer. Then, it’s publication day for Andrew Ross Sorkin’s new book 1929, which details the stock market crash that reshaped American capitalism. Plus, China sanctions a South Korean shipbuilder accused of aiding the U.S., and President Trump weighs in on a two-state solution and rebuilding Gaza.
Joaquin Duato - 10:25
In this episode:
Joe Kernen, @JoeSquawk
Becky Quick, @BeckyQuick
Andrew Ross Sorkin, @andrewrsorkin
Cameron Costa, @CameronCostaNY
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Squawk Pod
What Pablo Torre Found Out & Banning Artificial Superintelligence 9/4/26
Squawk Pod
Nvidia Buys Hugging Face 9/3/26
Squawk Pod
Berkshire Hathaway CEO Greg Abel & Sec. Lutnick Blames Canada 9/2/26
Squawk Pod
Apple’s New CEO & Mayor Mamdani’s Business Council 9/1/26
Squawk Pod